Beat Childhood Cancer Specimen Banking and Data Registry
NCT04715178 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-02-03
Summary
This is an observational data registry study of pediatric cancer patients at participating Beat Childhood Cancer Consortium sites involving specimen banking and data collection.
Conditions
- Pediatric Cancer
- Survivorship
Interventions
- OTHER
-
No intervention- registry only
No intervention- registry only
Sponsors & Collaborators
-
Giselle Sholler
lead OTHER
Principal Investigators
-
Giselle Sholler, MD · Beat Childhood Cancer
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-02
- Primary Completion
- 2031-01-31
- Completion
- 2032-01-31
Countries
- United States
Study Locations
More Related Trials
-
Molecular-Guided Therapy for Childhood Cancer
NCT02162732 ·Status: COMPLETED ·Phase: NA
-
Gemcitabine in Treating Children With Refractory Solid Tumors
NCT00005577 ·Status: COMPLETED ·Phase: PHASE1
-
LIFE Cancer Survivorship Database for Pediatric Cancer
NCT01518400 ·Status: RECRUITING
-
A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer
NCT03215511 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers
NCT06171971 ·Status: RECRUITING
-
Antibiotic Resistance in Global Pediatric Oncology Centers
NCT03721562 ·Status: COMPLETED
-
Paediatric Hepatic International Tumour Trial
NCT03017326 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
NCT03590171 ·Status: RECRUITING ·Phase: PHASE2
-
CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma
NCT04726501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours
NCT02303028 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies
NCT01858571 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
NCT00091091 ·Status: COMPLETED
-
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
NCT06942039 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
NCT02343718 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
NCT00025259 ·Status: COMPLETED ·Phase: PHASE3
-
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
NCT00165139 ·Status: COMPLETED ·Phase: PHASE2
-
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
NCT02638428 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
NCT03936465 ·Status: COMPLETED ·Phase: PHASE1
-
Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
NCT01187810 ·Status: TERMINATED ·Phase: PHASE1
-
Three Times Weekly Symptom Screening for Children With Cancer
NCT04275102 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
NCT03628131 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
NCT00897871 ·Status: UNKNOWN
-
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
NCT00003096 ·Status: COMPLETED
-
Therapy for Pediatric Hodgkin Lymphoma
NCT00145600 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors
NCT04671901 ·Status: TERMINATED ·Phase: PHASE2